On the advisability of splenic hilar lymphadenectomy in gastric cancer

Authors:

Abstract
The purpose of the study: to analyze the rationale for routine splenectomy or splenic hilar lymphadenectomy in gastric cancer (GC) surgery through a comparative study of spleen-preserving and splenectomy techniques, and an investigation of the patterns and clinical impact of metastasis of the splenic hilar lymph nodes (SHLN). Material and Methods. A retrospective analysis on data from 264 patients with stage I–III gastric cancer (GC) treated at the Voronezh Regional Scientific and Clinical Oncology Center between 2013 and 2018 was conducted. After examination, all patients underwent total gastrectomy with D2 lymphadenectomy with or without splenectomy (R0 resection). XELOX/FOLFOX adjuvant chemotherapy was utilized if indicated. the median follow-up time was 61 [19–80] months. Results. Metastases to SHLN were found in 19 (7.2 %) patients and were associated with advanced GC (T3–4/N2+) (OR 9.8; 95 % CI 6.76–14.2; pConclusion. Metastatic involvement of SHLN is associated with locally advanced tumor progression, an unfavorable course of the early postoperative period, and reduced survival in patients with GC. The obtained data emphasize the need for further investigation of a selective approach to lymphadenectomy in this area.

This publication has 12 references indexed in Scilit: